证券日报网讯凯因科技8月7日在互动平台回答投资者提问时表示，公司目前间接持有先为达3.44%的股 权。关于先为达的药物进展情况请以其对外发布内容为准。公司与先为达就其在研GLP-1药物签订协 议，针对该药品产生的未来收益形成相关约定，具体情况请参考公司过往披露的公开信息。 ...

格隆汇8月7日丨凯因科技(688687.SH)在投资者互动平台表示，公司当前重点聚焦以创新药为核心的乙 肝功能性治愈药物组合研发，同时布局免疫性疾病领域提高预防保护率与临床治愈率的创新药物管线。 ...

凯因科技8月1日披露，截至7月31日公司股东户数为11199户，较上期（7月20日）减少827户，环比降幅 为6.88%。 证券时报·数据宝统计，截至发稿，凯因科技收盘价为35.95元，上涨2.13%，本期筹码集中以来股价累 计上涨11.85%。具体到各交易日，7次上涨，3次下跌。 公司发布的一季报数据显示，一季度公司共实现营业收入2.32亿元，同比增长8.90%，实现净利润 2566.85万元，同比增长15.92%，基本每股收益为0.1500元，加权平均净资产收益率1.38%。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） ...

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 company secretaries earn over 1 million yuan annually, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary for company secretaries in the biopharmaceutical sector is 1.01 million yuan [5] - The distribution of salaries among company secretaries is as follows: below 500,000 yuan (15%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (38%), 2,000,000-3,000,000 yuan (4%), and above 3,000,000 yuan (2%) [5] Age and Education Distribution - The age distribution of company secretaries shows that those aged 40-50 make up 61%, while those over 50 account for 15%, and those aged 30-40 account for 18% [1] - In terms of education, 52% of company secretaries hold a bachelor's degree, while 44% have a master's degree, and only 2% have a doctoral degree [3] Investor Engagement - There is significant variation in the number of investor meetings held by companies, with 43% of companies hosting fewer than 10 meetings annually [7] - The top five companies with the highest number of investor meetings are: Bohui Innovation (1,500 meetings), Jindike (777 meetings), Nearshore Protein (681 meetings), Sailun Biotech (549 meetings), and Kanghua Biotech (504 meetings) [9]

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 secretaries earned over 1 million yuan annually, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary for secretaries in the A-share biopharmaceutical sector is 1.01 million yuan [5] - The distribution of salaries is as follows: below 500,000 yuan (15%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (38%), 2,000,000-3,000,000 yuan (4%), and above 3,000,000 yuan (2%) [5] Age and Education Distribution - The age distribution of secretaries shows that those aged 40-50 constitute 61%, while those over 50 account for 15%, and those aged 30-40 make up 18% [1] - In terms of education, 52% of secretaries hold a bachelor's degree, while 44% have a master's degree, and only 2% possess a doctoral degree [3] Investor Engagement - There is significant variation in the number of investor meetings held by companies, with 43% of companies hosting fewer than 10 meetings annually [7] - The top five companies with the highest number of investor meetings are: Bohui Innovation (1,500 meetings), Jindike (777 meetings), Nearshore Protein (681 meetings), Sailun Biotech (549 meetings), and Kanghua Biotech (504 meetings) [9]

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - Over 21% of company secretaries earn more than 1 million yuan annually, indicating a significant portion of high earners in this role [1] Salary Distribution - The average annual salary for company secretaries in the biopharmaceutical sector is 1.01 million yuan, with the distribution of salaries as follows: below 500,000 yuan (15%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (38%), 2,000,000-3,000,000 yuan (4%), and above 3,000,000 yuan (2%) [5] - The top five highest-paid company secretaries have salaries of 3.2565 million yuan, 2.5345 million yuan, 2.2809 million yuan, 1.9265 million yuan, and 1.89 million yuan, with their tenure at the companies ranging from less than one year to 15 years [7] Age and Educational Background - The age distribution of company secretaries shows that those aged 40-50 constitute 61%, while those over 50 account for 15%, and those under 30 make up 6% [1][3] - The educational background indicates that 52% hold a bachelor's degree, 44% have a master's degree, and only 2% possess a doctoral degree, with the latter represented by just one individual [3] Investor Engagement - There is a significant variance in the number of investor meetings held by companies, with 43% of companies hosting fewer than 10 meetings annually, while only 2% have more than 1,000 meetings [9] - The five companies with the highest number of investor meetings are reported to have 1,500, 777, 681, 549, and 504 meetings, respectively [9]

Group 1 - The first meeting of the 2025 Employee Stock Ownership Plan (ESOP) was held on July 16, 2025, with 83 participants representing 100% of the total shares in the plan [1][2] - The meeting approved the establishment of a management committee for the 2025 ESOP to oversee daily management and protect the rights of shareholders [2][3] - The management committee consists of three members, with a term aligned with the duration of the 2025 ESOP [2][3] Group 2 - The meeting elected Liu Zixin, Li Xiaoqing, and Liu Yanhui as committee members, ensuring no conflicts of interest with company executives [2][3] - The first committee meeting subsequently elected Liu Zixin as the committee chair [3] - The committee was authorized to manage various aspects of the ESOP, including qualification decisions, asset management, and representation of shareholders [4]

Core Points - Beijing Kain Technology Co., Ltd. has completed the stock transfer for its 2025 employee stock ownership plan, with a total of 83 employees participating and the total subscription amount fully paid [1][2] - The company has repurchased 3,509,027 shares at a price of 12.84 yuan per share, representing 2.05% of the company's total share capital [2] - The employee stock ownership plan has a duration of 36 months, with stock unlocking occurring in two phases at 12 and 24 months, each unlocking 50% of the shares based on company performance and individual assessments [2]

证券代码：688687 证券简称：凯因科技 公告编号：2025-025 一、持有人会议召开情况 北京凯因科技股份有限公司（以下简称"公司"）2025年员工持股计划第一 次持有人会议（以下简称"本次会议"）于2025年7月16日以现场结合通讯表决方 式召开，由公司副总裁、董事会秘书兼首席人力资源官王湛先生召集和主持。本 次会议应出席持有人83人，实际出席持有人83人，代表公司2025年员工持股计划 份额45,055,906.68份，占本次员工持股计划总份额的100.00%。参与本次员工持 股计划的公司董事、监事、高级管理人员及其关联人自愿放弃其在持有人会议的 提案权、表决权，且不担任管理委员会的任何职务，上述持有人均不参与本次会 议的表决，参与本次会议的有效表决权份额总数为20,146,306.68份。 本次会议的召集、召开和表决程序符合有关法律法规及《北京凯因科技股份 有限公司2025年员工持股计划（草案）》和《北京凯因科技股份有限公司2025年 员工持股计划管理办法》的有关规定。 二、持有人会议审议情况 北京凯因科技股份有限公司 2025 年员工持股计划第一次持有人会议决议公告 本公司董事会及全体董事保证本 ...

北京凯因科技股份有限公司（以下简称"公司"）分别于2025年4月28日、 2025年5月20日召开第六届董事会第六次会议、第六届监事会第五次会议及2024 年年度股东大会，审议通过了《关于〈公司2025年员工持股计划（草案）〉及其 摘要的议案》等议案，具体内容详见公司于2025年4月29日、2025年5月21日在上 海证券交易所网站（www.sse.com.cn）披露的相关公告。 根据《关于上市公司实施员工持股计划试点的指导意见》《上海证券交易所 科创板上市公司自律监管指引第 1 号——规范运作》等法律法规的相关规定，现 将公司 2025 年员工持股计划(以下简称"员工持股计划")实施进展情况公告如 下： 根据参与对象实际认购和最终缴款的审验结果，本次员工持股计划实际参与 认购的员工共计 83 人，认购资金已全部实缴到位，最终缴纳的认购资金总额为 45,055,906.68 元，认购份额对应股份数量为 3,509,027 股，股票来源为公司回 购专用证券账户回购的公司 A 股普通股股票。 证券代码：688687 证券简称：凯因科技 公告编号：2025-024 北京凯因科技股份有限公司 关于 2025 年员工持 ...